Patents

Antares Pharma Announces Issuance of Key Patent Covering ATD(TM) Technology

Published in Medical Patent Law Weekly, April 23rd, 2008

Antares Pharma, Inc. (Amex:AIS) announced that a second patent extension covering its proprietary Advanced Transdermal Delivery (ATD(TM)) Gel System has been issued by the United States Patent and Trademark Office. The patent was issued on February 26, 2008 and is in effect until August 2021. Antares is the sole owner of the newly issued patent.

"The issuance of this patent is an important achievement in the strengthening of Antares Pharma's Intellectual Property portfolio," said Dario N. R. Carrara, Senior Vice President and Managing Director of the Pharmaceutical Group. "Initially developed for the transdermal delivery of hormones, ATD Technology exhibited the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly

Source: Medical Patent Law Weekly (2008-04-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry